2015 U.S.-Booked Air
Volume: $45
million
GSK air travel emitted
102,000 tons of CO2 in 2015, up from 94,000 in 2014, according to its annual
report. The pharmaceutical company employed 101,255 people based in more than
150 countries. Thanks to increased monitoring, T&E’s share of the company
policy violations committed by employees rose from 3 percent in 2014 to 10
percent in 2015, according to the company’s annual report. Of the 387 people
dismissed from the company, 130 left the company because of T&E violations,
the most common reason.
The global healthcare
company’s GSK revenue totaled GBP23.9 billion or US$31.6 billion, in 2015, up
from $23 billion in 2014. GSK completed several acquisitions in 2015, including
vaccine developer GlycoVaxyn. GSK also acquired Novartis’ global vaccine
business, excluding influenza vaccines, while Novartis acquired GSK’s oncology
business. The companies also created a consumer health joint venture.
Additionally, GSK divested its portfolio of over-the-counter brands and its
meningitis vaccines. The healthcare company is continuing its M&A streak in
2016. In February it acquired Bristol-Myers Squibb’s HIV portfolio. It has also
divested its anesthesia, thrombosis and dermatology foam businesses.